HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Franz E Weber Selected Research

N-methylpyrrolidone

10/2019Epigenetic drugs as new therapy for tumor necrosis factor-α-compromised bone healing.
10/2018The Bromodomain Inhibitor N-Methyl pyrrolidone Prevents Osteoporosis and BMP-Triggered Sclerostin Expression in Osteocytes.
1/2016The bromodomain inhibitor N-methyl pyrrolidone reduced fat accumulation in an ovariectomized rat model.
9/2015The epigenetically active small chemical N-methyl pyrrolidone (NMP) prevents estrogen depletion induced osteoporosis.
7/2015N-methyl pyrrolidone (NMP) inhibits lipopolysaccharide-induced inflammation by suppressing NF-κB signaling.
7/2011Inhibition of osteoclast differentiation and bone resorption by N-methylpyrrolidone.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Franz E Weber Research Topics

Disease

4Osteoporosis
10/2018 - 09/2015
4Wounds and Injuries (Trauma)
01/2018 - 12/2003
3Inflammation (Inflammations)
01/2020 - 07/2015
3Bone Resorption
10/2018 - 07/2011
2Fibrosis (Cirrhosis)
05/2017 - 03/2016
1Infertility (Sterility)
10/2020
1Neoplasms (Cancer)
09/2016
1Crohn Disease (Crohn's Disease)
03/2016
1Idiopathic Pulmonary Fibrosis
03/2016
1Weight Gain
01/2016
1Body Weight (Weight, Body)
01/2016
1Male Infertility (Male Sterility)
04/2015
1Low Back Pain (Lumbago)
01/2015
1Intervertebral Disc Degeneration
01/2015
1Spontaneous Remission
03/2007
1Hematoma
03/2004
1Heterotopic Ossification (Ectopic Ossification)
12/2003

Drug/Important Bio-Agent (IBA)

6N-methylpyrrolidoneIBA
10/2019 - 07/2011
3dimethylacetamideIBA
10/2020 - 01/2017
3Estrogens (Estrogen)FDA Link
10/2018 - 09/2015
2Excipients (Suspending Agents)IBA
10/2020 - 01/2017
2Pharmaceutical PreparationsIBA
10/2018 - 01/2017
2CytokinesIBA
09/2015 - 07/2015
2FibrinIBA
01/2015 - 03/2004
1AdipokinesIBA
01/2020
1Therapeutic UsesIBA
10/2019
1Bone Morphogenetic Protein 2IBA
10/2018
1Bone SubstitutesIBA
01/2018
1LigandsIBA
01/2017
1pirfenidoneIBA
03/2016
1LeptinIBA
01/2016
1ChemokinesIBA
07/2015
1LipopolysaccharidesIBA
07/2015
1ProteomeIBA
07/2015
1Hyaluronic Acid (Hyaluronan)IBA
01/2015
1HydrogelsIBA
01/2015
1Cathepsin KIBA
07/2011
1Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
03/2007
1Peptides (Polypeptides)IBA
03/2007
1Parathyroid Hormone (Parathormone)IBA
03/2007

Therapy/Procedure

2Therapeutics
10/2019 - 05/2017
2Oral Surgery (Maxillofacial Surgery)
01/2018 - 09/2016
2Spinal Fusion (Spondylosyndesis)
04/2015 - 01/2015
1Aftercare (After-Treatment)
03/2016
1Ovariectomy (Oophorectomy)
01/2016
1Hip Replacement Arthroplasty (Total Hip Replacement)
12/2003